BioMedical Technology Solutions Holdings, Inc. (OTCBB: BMTL) has been quiet for many months, but broke the silence today with news of the execution of a new national distribution agreement with McKesson Medical-Surgical, Inc. and subsequent sales.  McKesson has more than 300,000 customers and hundreds of sales representatives who will now be selling the BMTS Demolizer II medical waste processing systems. McKesson immediately upon execution sold multiple units and presented purchase orders to BMTS.


Company President and Chairman Gex “Jay” F. Richardson commented,

We are pleased to add such a great company to our distribution network. We are already realizing orders from McKesson customers and expect the orders to grow exponentially.

Shares of BMTL were trading in the area of 30 cents each at this time last year, but have since depreciated to $0.02 throughout 2011 since removing Donald Cox as Chief Executive Officer in January and going through a PR drought which only produced a handful of news early in the summer.  Perhaps these new sales and distribution agreement will get the company cranking in 2012 as it has a tiny float of approximately 8 million shares, a completely unique product and a strong upside potential for its $670,000 market capitalization should the ball get rolling.

BioMedical Technology Solutions Holdings (BMTL) Stock Quote and News:

---

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. In September 2010, Viper Enterprises, LLC (parent company of OTC Showcase) received receive 50,000 restricted shares of BMTL as compensation for providing company information, market awareness, consultation and journalism services from Biomedical Technology Solutions Holdings, Inc. (180 days of services). The restriction has been lifted and the shares are still being held. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.